Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio.
about
A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancerPancreatic Cancer: 80 Years of Surgery-Percentage and RepetitionsAdjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data.Validation of group B borderline resectable pancreatic cancer: retrospective analysis.Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience.Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas.Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisationLong-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-Analysis.The indolent nature of pulmonary metastases from ductal adenocarcinoma of the pancreasSurveillance of pancreatic cancer patients after surgical resection.Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic CancerYield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapyImpact of sarcopenia on outcomes following resection of pancreatic adenocarcinomaRe-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.Impact of preoperative therapy on patterns of recurrence in pancreatic cancerHormophysa triquerta polyphenol, an elixir that deters CXCR4- and COX2-dependent dissemination destiny of treatment-resistant pancreatic cancer cells.Extended lymphadenectomy in patients with pancreatic cancer is debatable.The importance of surgical margins in pancreatic cancer.Defining the possible therapeutic benefit of lymphadenectomy among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma.Peripancreatic fat invasion is an independent predictor of poor outcome following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Proposal for a Revised N Classification for TNM Staging.New possibilities and potential benefits for local control in locally recurrent pancreatic cancer.Comparison of four target volume definitions for pancreatic cancer. Guidelines for treatment of the lymphatics and the primary tumor.Expression of Beclin 1 and Bcl-2 in pancreatic neoplasms and its effect on pancreatic ductal adenocarcinoma prognosis.Preoperative sarcopenia and post-operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer.Patient-derived organoid models help define personalized management of gastrointestinal cancer.Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and Effective.Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy.Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysis.
P2860
Q24629242-3A61D9A2-A55B-46B1-9434-8067C1772349Q28072182-A157ECC2-57A5-4622-9953-25980733835BQ30580152-B6FA1924-33F3-4139-A55E-82894B0DF4B3Q34182126-87953B4A-17D5-4E26-8BF1-0DF7AE9186EAQ34667324-26CB1005-67E2-4C32-8BC0-35A1EFFFFDB9Q35161198-52BEB800-C17E-4AEB-BD7C-396C81B6BCA9Q35678372-AED7B581-C9D6-46FF-A2E9-234C24553B0AQ35724058-5E03ABA5-043B-47C1-B9CA-7D8E798A8356Q35875608-157A2EC0-C8D6-4DB9-A67E-71CD47A3030EQ35990105-5A82AE31-E1F9-4D8A-9FEF-EED9F333B3DEQ36058855-58EB2366-DFC7-463A-8809-DD7E67FE08BEQ36063299-8A1EEB94-FBA9-4FA0-BC5F-D0B95BB9C287Q36626534-AB715BA5-E61C-4ED2-A838-3E3B329AE6B3Q37285956-EAA542A2-FE5A-4537-99A7-4277750AFE34Q37480832-01095727-6E63-4AC8-AA74-3740D65934EBQ37701468-FB1A6D5F-C666-4966-9B36-917958BD25F5Q38106907-E14E922A-E02C-4B3D-ABD1-47B8817C9AB0Q38646898-455FA58E-C5D1-4DB3-BCA6-50708AB3E9F1Q38900780-14AF0808-EC51-4A23-B9D6-F021E20043F9Q39811833-FADFF750-94BE-4CA6-A4D2-23D46FFEB113Q41371326-1CCCA55E-CD26-4B78-BFD3-B6FC8C4E515CQ42919208-FE29E72B-938C-47B2-8032-2D25CC231D19Q45118772-435BEB1F-8456-439D-932C-23A36DA90600Q49271879-C3E8A693-643B-4DAC-93B8-BEBCE94419A7Q49330164-C0B34092-EC7B-4130-B8FF-D1C326D64F51Q50010294-41493B74-EF25-47A6-BE11-047D1F11F8B9Q50074188-0FB1C980-7725-4867-8762-FE2A976A3067Q51442653-7511466C-4AF5-4338-B04E-FF688134BFAEQ51831319-079D8252-37CF-42EC-A6CE-33EF2D0DE847
P2860
Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Determining pattern of recurre ...... ph nodes and lymph node ratio.
@en
Determining pattern of recurre ...... ph nodes and lymph node ratio.
@nl
type
label
Determining pattern of recurre ...... ph nodes and lymph node ratio.
@en
Determining pattern of recurre ...... ph nodes and lymph node ratio.
@nl
prefLabel
Determining pattern of recurre ...... ph nodes and lymph node ratio.
@en
Determining pattern of recurre ...... ph nodes and lymph node ratio.
@nl
P2093
P2860
P921
P1476
Determining pattern of recurre ...... ph nodes and lymph node ratio.
@en
P2093
Ana Gleisner
Barish H Edil
Bolanle Asiyanbola
Christopher L Wolfgang
John L Cameron
Joseph M Herman
Michael A Choti
Michael Swartz
Richard D Schulick
P2860
P2888
P304
P356
10.1007/S11605-008-0762-X
P577
2008-12-17T00:00:00Z